leukaemia Flashcards

1
Q

leukimia is the malignancy of— in the bone marrow with an
excess of “ – ” cells i.e. abnormal — — blood cells
* Disease of white blood cells: — or —
* May be acute or chronic
* Symptoms and signs related to
– — replacement
* Reduced RBCs, WBCs and platelets
– —
– +/- Bone pain
– +/- —

A

white blood cells
blast cells
immature white blood cells
myeloid or lymphocyte
marrow
hypervsicoty
lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  • Flow cytometry/immunophenotyping can help identify the – of blood cell by assessing — , – and — of different cell antigens
  • SSC = Side scatter: this assesses the – of the cell
  • FSC = Forward scatter: this assesses the – of the cell
A

type
size
grnaulaty
granularity
size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

disorders of white blood cells:
* Reactive increase in number – “philias”/osis
* — : – bacterial sepsis, steroid use
* —- : – viral infection, immune causes
* — : – allergy, parasites, drugs
* Decrease in number – “penias”
– Neutropenia, Lymphopenia & Eosinopenia,
Pancytopenia (reduction in all cells)
– Causes of penias: drugs, viral infections,
radiation, chemotherapy etc.
Learn the language

A

neurophilia
lymphocytosis
esinotphilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  • —- : increased number of blast cells in bone marrow
    and blood
  • Classification:
    – – / –
    – — / –
  • — : Nodal and extra nodal
    – Hodgkins
    – Non-Hodgkins
  • Large – lymphoma, – Lymphoma most common
  • Other cancers of myeloid lineage
    – Myeloproliferative neoplasms
    – Myelodysplastic syndromes
A

leukimia
acute/chronic
myloid/lymphoid
lymphoma
large b and follicular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

leukemia is the increased number of — cells in — and —
1-Acute Leukaemias
Broadly divided into:
–Acute myeloid leukaemia (AML)
–Acute lymphoblastic leukaemia (ALL – can be – or – origin)
–Several molecular subtypes of both AML and ALL
2-Chronic Leukaemias
Common examples include:
Chronic myeloid leukaemia ( – lineage)
Chronic lymphocytic leukaemia (– lineage)

A

b and t cells
myeloid
b cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

clinical features:
The onset of bone marrow failure and symptoms is rapid in – leukaemias
but can be more insidious in – leukeamias
* Bone marrow replacement by blast cells with marrow failure
– Anaemia (low haemoglobin)
– Fever - Infections ( caused by low white cells)
– Bleeding tendency (low platelets and coagulopathy including DIC)
* Bone pain (caused by bone marrow expansion and hypoxia)
* Weight loss
* Night sweats
* Lymphadenopathy (more commonly seen in childhood ALL)
* Enlarged thymus
– Usually presents as SOB in T-ALL in young children, can cause a
widening of mediastinum on chest x-ray
* Enlarged testes – most commonly seen in ALL
* Splenomegaly – more commonly seen in – leukaemias

A

acute
chronic
chronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

acute myeloid ( myeloblastic) leukaemia aka AML :
* Arises from the –
transformation of a myeloid precursor
* 80% of cases occur in –
* Most frequent leukemia in –
* The incidence increases with –
specific manifestation:
* Low blood counts secondary to bone marrow invasion can lead to initial
symptoms of fatigue, recurrent infections, weight loss, bruising, gum
bleeding and intracranial bleeding causing headache or collapse
* Solid tumours can form from leukaemia in these patients – known as
myeloid sarcoma
* Rarely gum tissue invasion causes gum hypertrophy
* Skin deposits can be seen but this is rare
* Tumour lysis syndrome caused by the rapid breakdown of leukemia cells can cause renal failure – this can be spontaneous or induced by the initiation of cytotoxic chemotherapy
* Coagulopathy – disseminated intravascular coagulation – most commonly associated with a subtype of AML called Acute Promyelocytic Leukaemia–
APML

A

malignant
adults
neonate
age
( AML-GUM hypertrophy is the infiltration of gums by leuameic cells )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • Accounts for 85% of childhood leukaemia
  • In children - most common malignant disease
  • Incidence decreases with age, with a second rise after 40
    years.
    is known as –
    -Similar to AML in terms of bone marrow — manifestations
    -Clinically can be – to tell the difference between AML and ALL at diagnosis
    -More likely to have – , – mass or — involvement
A

acute lymphoblastic leukaemia ALL
invasion
difficult
adenopathy thymic mass and testicular involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

investigation of acute leukaemia:

A

Understand the reason for each test you order!!
* FBC – Hb, platetets, white cell differential count – what does
this mean?
* Blood film – what can you expect to see?
* Coag– PT, APTT, Fibrinogen
* Lactate dehydrogenase
* Renal function, liver function – why is this needed?
* Bone marrow aspirate and trephine
* Immunophenotyping by flow cytometry to determine the type
of cell
* Molecular analysis of DNA inside the leukaemia cells – what
can this tell you?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

investigate of acute leukaemia:
1- full blood count:
WCC <1.0x109/l to >200x109/l, white cells and – blast cells
* Anaemia: reduced
haemoglobin normochromic, normocytic
* Thrombocytopenia
(Often <10x109/l)
2- bone marrow aspiration and trephine biopsy:
 Confirm acute
leukaemia
 Blasts are counted
 Flow cytometry
 Molecular analysis
 Immunohistochemistry
3- immunophenotyping as —- which determine whether the leykimia is — or —
- molecular test help detecte relevant — as:
* t(8;21) AML (Core binding factor AML- good
prognosis)
* t(4;11) ALL (MLL re-arranged ALL- poor
prognosis in adults)

A

increased
flow cytometry
lymphoid or myeloid
rearrangement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

management of acute leukaemia:

A
  • Chemotherapy
  • +/- Bone marrow transplant (BMT) – can be from sibling or
    unrelated donor
  • The decision for a BMT or not is complex – depends largely on
    cytogenetic subgroup at diagnosis
    Supportive care to keep patient alive while chemo is trying to work.
  • Treat infection with antibiotics
  • Treat Bleeding
    – Platelet transfusion for bleeding episodes and to prevent
    intracranial haemorrhage (ICH)
    – Fresh frozen plasma (FFP) to prevent bleeding and ICH
    – Fibrinogen to manage DIC – can be fatal despite the leukaemia
    itself being a curable disease
    – Red cell transfusion for severe anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

chronic myeloid leukaemia which is malignancy of —-
* Median age 40-60y
* – chromosome, t(—)
* Marrow replacement +/- failure:
– – , – & —
* Marked — – >50,000
(abnormal)
* Marked – , —

A

myeloid marrow cells
Philadelphia (9:22)
anemia fever and bleeding
leucytosis
splenomegaly and hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

diagnosis of CML:
* Clinical examination and history – what do you expect to hear
and find?
* FBC
* Blood film
* Coagulation screen
* Bone marrow aspirate and trephine
* — testing using PCR or NGS: t(9;22) (Philadelphia chromosome) and – fusion gene

A

molecular testing
BCR-ABL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

principle of treatment of CML:
* Relieve constitutional symptoms of :
– Fluids, hydroxyurea for cytoreduction
– Chemotherapy sometimes needed
– — Inhibitor treatment has been a major breakthrough in cancer
(e.g. Imatinib/Dasatinib/Nilotinib)
– +/- bone marrow transplant in rare refractory cases

A

leukocytosis, splenomegaly and thrombocytosis
Longterm Tyrosine Kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

chronic lymphocytic leukaemia CLL which is maligancy of —
* Malignancy of –
* Usually presents in – phase
* Marrow failure – often – development over
years
* – – usually an incidental discovery on FBC with GP, patient otherwise well
* Generalised —

A

bone marrow lymphocyte
mature lymphocyte
asymptomatic
slow development
lymphocytosis
lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

1-diagnosis of CLL:
* FBC
* Blood film
* Bone marrow aspirate and trephine
* Immunophenotyping
* Molecular tests (help determine treatment options and
prognosis)
2- management/treatment of leukemia:
* Supportive care– keep patient alive until treatment
works
* – in acute leukaemias eg daunorubicin and cytarabine in —
* — inhibitors have been a major breakthrough in CLL this decade
* Increasing numbers of targeted treatments formolecular subgroups in AML e.g. IDH1 inhibitors, FLT3
inhibitors
* Tyrosine Kinase inhibitors in CML targeting the BCR- ABL protein
* CLL: treatment required if disease is – . Can “watch and wait” if stable

A

chemo
AML
Bruton tyrosine kinase
progress

17
Q

summary:
* Acute leukaemia: – and – (B/T)
* Chronic leukaemia: – and –
* Diagnosis, history and clinical exam and special tests
* Tests
– FBC
– Blood film
– Renal, liver, LDH, coag
– BMA and BMT
– — (usually by flow cytometry)
– Molecular analysis
* Treatment
– Supportive care
– —
– Novel molecularly — agents
– – in CML
– +/- — Transplant

A

myloid ad lymphoblastic
myeloid and lymphocytic
immuniphenotyping
chemo
target
TKIS
bone marrow